psoriasis

Burshtein J, Armstrong A, Chow M, DeBusk L, Glick B, Gottlieb AB, Gold LS, Korman NJ, Lio P, Merola J, Rosmarin D, Rosenberg A, Van[...]

By sjmartinez • December 22, 2024

Tada Y, Armstrong AW, Imafuku S, Okubo Y, Morita A, Zhong Y, Zhuo J, Becker B, Napoli A, Banerjee S, Ohtsuki M. Deucravacitinib in Japanese[...]

By sjmartinez • December 7, 2024

Sadrolashrafi K, Hao A, Yamamoto RK, Guo L, Kikuchi R, Tolson HC, Bilimoria SN, Yee DK, Armstrong AW. The impact of insurance status on psoriasis[...]

By sjmartinez • December 2, 2024

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL Jr, Mangin GD, Jacobson AA. Brodalumab: Six-Year US Pharmacovigilance Report. Dermatol[...]

By sjmartinez • November 27, 2024

Tsai TF, Tada Y, Kung C, Zhong Y, Cichewicz A, Borkowska K, Westley T, Kisa RM, Huang YH, Gao XH, Jo SJ, Armstrong AW. Indirect[...]

By sjmartinez • November 14, 2024

Guo L, Bilimoria SN, Kikuchi R, Hao A, Sadrolashrafi K, Yamamoto RK, Tolson H, Yee D, Armstrong AW. Chronic Obstructive Pulmonary Disease Outcomes in Psoriasis[...]

By sjmartinez • November 14, 2024

Warren RB, Donnelly K, Kiri S, Taieb V, Slim M, Fahrbach K, Neupane B, Betts M, Armstrong A. Long-Term Efficacy and Safety of Bimekizumab and[...]

By sjmartinez • November 2, 2024

Korouri E, Jeong C, Peterson H, Valenzuela F, Romiti R, Didaskalu JA, Egeberg A, Oon HH, Maul LV, Kingston P, Lee K, Huang MY, Yee[...]

By sjmartinez • October 27, 2024

Armstrong AW, Foley P, Liu Y, Miller M, Teneralli RE, Bewley A, Gordon KB, Papp KA, Han C. Direct and Indirect Effect of Guselkumab on[...]

By sjmartinez • August 24, 2024

James WA, Rosenberg AL, Wu JJ, Hsu S, Armstrong A, Wallace EB, Lee LW, Merola J, Schwartzman S, Gladman D, Liu C, Koo J, Hawkes[...]

By sjmartinez • July 22, 2024